Cellular and Molecular Abnormalities in the Vascular Endothelium of Diabetes Mellitus

George L. King(Joslin Diabetes Center), Sven–Erik Bursell(Joslin Diabetes Center), Toyoshi Inoguchi(Kyushu University), Teruo Shiba(Joslin Diabetes Center), F. Javier Oliver(Instituto de Parasitología y Biomedicina "López - Neyra")
Annual Review of Medicine
February 1, 1994
10.1146/annurev.med.45.1.179
Cited by 129

Related Papers

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
|Science|1996|1.1k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979